XML 48 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Common stock - Additional Information (Detail) (USD $)
0 Months Ended 3 Months Ended 6 Months Ended 0 Months Ended 0 Months Ended
May 08, 2014
Mar. 06, 2014
Directors
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Aquinox USA [Member]
Dec. 31, 2013
Aquinox USA [Member]
Jun. 30, 2014
Aquinox USA [Member]
Biolipox AB [Member]
Jun. 30, 2014
Aquinox USA [Member]
Biolipox AB [Member]
Mar. 06, 2014
Non-employee Directors [Member]
Jan. 27, 2014
Equity Incentive Plan 2006 [Member]
Jan. 27, 2014
Equity Incentive Plan 2014 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                          
Stock options granted 175,500                   33,332 0  
Maximum number of shares of common stock that may be issued                         1,423,416
Common stock, shares outstanding                         756,279
Shares of common stock reserved for issuance description         Additionally, the number of shares of common stock reserved for issuance under the 2014 Plan will automatically increase on January 1 of each year for a period of up to 10 years, beginning on January 1, 2015 and ending on and including January 1, 2024, by 4% of the total number of shares of capital outstanding on December 31 of the preceding calendar year, or a lesser number of shares determined by the board of directors.                
Shares of common stock reserved for issuance percentage         4.00%                
Years of increase in shares of common stock reserved for issuance         10 years                
Exercise price per share of options granted to non-employee directors                     $ 11.00    
Number of non-employee directors   4                      
Exercise price per share $ 10.10                        
Stock-based compensation expense     $ 214,822 $ 73,483 $ 352,476 $ 128,157              
Unrecognized stock-based compensation cost     3,043,734   3,043,734                
Unrecognized stock-based compensation cost, weighted-average period recognized         2 years 8 months 9 days                
Common stock, shares authorized             50,000,000 139,266,037          
Common stock, par value             $ 0.000001 $ 0.000001          
Common stock, shares issued             10,695,022 301,745   19,762      
Fair value of shares issued                 $ 186,356        
Common stock, shares outstanding             10,695,022 301,745